Tin tức & Cập nhật

How does IV edaravone fare for ALS in the real world?
How does IV edaravone fare for ALS in the real world?
10 May 2022
AChEIs and memantine cost-effective, offer improvements in AD
AChEIs and memantine cost-effective, offer improvements in AD
09 May 2022 bởiNatalia Reoutova

A systematic review and meta-analysis of Alzheimer’s disease (AD) therapies’ cost-effectiveness carried out by researchers from the Chinese University of Hong Kong (CUHK) identifies acetylcholinesterase inhibitors (AChEIs) and memantine as cost-effective and offering improvements in dementia-related symptoms.

AChEIs and memantine cost-effective, offer improvements in AD
09 May 2022
Platelet function a potential biomarker of Alzheimer’s disease
Platelet function a potential biomarker of Alzheimer’s disease
07 May 2022